NCT00450554已完成不适用
EVALUATION DE LA REPONSE IMMUNITAIRE CONTRE LA SOUCHE DE NEISSERIA MENINGITIDIS B:14,P1.7,16
University Hospital, Rouen1 个研究点 分布在 1 个国家目标入组 236 人开始时间: 2007年2月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 236
- 试验地点
- 1
研究概览
简要总结
The main objective of the study is to estimate the proportion of children, born between the 01/01/2002 and the 06/23/200, living around Dieppe (cantons Dieppe est, Dieppe Ouest and Offranville), vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (>= 4), before and after the third MenBvac vaccination.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 2 Years 至 7 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •children born between 01/01/2000 and 06/23/2005, living in Dieppe-Est, Dieppe-Ouest and Offranville, vaccinated twice by MenBVac
- •parental authority(ies)assent
排除标准
- •no parental authority(ies)assent
- •no blood sample during the third vaccination
- •impossibility of third vaccination
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-CSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Multisystem Inflammatory Syndrome in Children (MIS-C)Coronavirus Disease 2019 (COVID-19)NCT04588363National Institute of Allergy and Infectious Diseases (NIAID)244
已完成
4 期
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Have to be Vaccinated MenBVac®VaccinationNCT01054053University Hospital, Rouen218
已完成
3 期
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)Neisseria MeningitidisNCT01621945University Hospital, Rouen120
已完成
不适用
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19COVID-19 InfectionNCT04355533Assistance Publique - Hôpitaux de Paris1,056
已完成
3 期
Hepatitis B Challenge Dose in Adults (V232-059-10)Hepatitis BNCT01251276Merck Sharp & Dohme LLC204